—

Venrock Adviser, LLC

Q1 2026 13F Holdings

  • Location
    new york, NY
  • Num holdings

    33

  • Value ($000)

    $2,679,122

  • Date Filed
    05/15/2026
  • Form type
    13F-HR
  • CIK
    0001615982
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2026 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
A
APGE

APOGEE THERAPEUTICS INC

COM
03770N101
$714.88M
27 %

8,493,321

E
ERAS

ERASCA INC

COM
29479A108
$265.07M
10 %

16,382,812

---

ORUKA THERAPEUTICS INC

COM
687604108
$203.48M
8 %

4,148,428

S
SYRE

SPYRE THERAPEUTICS INC

COM NEW
00773J202
$185.89M
7 %

3,685,448

K
KALV

KALVISTA PHARMACEUTICALS INC

COM
483497103
$130.33M
5 %

6,474,485

D
DNTH

DIANTHUS THERAPEUTICS INC

COM
252828108
$99.03M
4 %

1,180,000

---

DAMORA THERAPEUTICS INC

COM NEW
36322Q206
$93.33M
4 %

3,603,595

O
OCUL

OCULAR THERAPEUTIX INC

COM
67576A100
$87.64M
3 %

10,346,926

C
COGT

COGENT BIOSCIENCES INC

COM
19240Q201
$76.98M
3 %

2,000,000

V
VRDN

VIRIDIAN THERAPEUTICS INC

COM
92790C104
$75.95M
3 %

3,882,709

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 33